| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 02/07/2008 | US20080033188 Selectively dehydrating carbohydrates, (preferably sugars, e.g., fructose, glucose, xylose) to yield furan derivatives such as 5-hydroxymethylfurfural (HMF) and furfural; cost-effective route for chemical intermediates |
| 02/07/2008 | US20080033187 Methods for conversion of carbohydrates in ionic liquids to value-added chemicals |
| 02/07/2008 | US20080033186 Method For Producing Nitriles By Elimination Of Water From Aldehyde Oximes With Alkylphosphonic Anhydrides |
| 02/07/2008 | US20080033176 Method for preparing prostaglandin derivative |
| 02/07/2008 | US20080033172 Mutagenic Heterocycles |
| 02/07/2008 | US20080033171 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants |
| 02/07/2008 | US20080033154 Process for Producing 3-Aminomethyltetrahydrofuran Derivative |
| 02/07/2008 | US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
| 02/07/2008 | US20080032979 Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors |
| 02/06/2008 | EP1883622A1 Substituted aryl oximes |
| 02/06/2008 | EP0773939B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 02/06/2008 | CN101120008A Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted dihydrobenzofurans |
| 02/06/2008 | CN101119984A Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted dihydrobenzofurans |
| 02/06/2008 | CN101117333A Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/06/2008 | CN100366338C Catalyst for preparing gamma-butyrolactone by normal pressure gas phase hydrogenation of maleic-anhydride and preparation process thereof |
| 02/05/2008 | US7326785 Preparation of 3-(thienylalkenylenesulfonylamino)-1-(4--morpholinylcarbonyl-alpha-substituted methyl)pyrrolidone derivatives: 2-(5-Chlorothien-2-yl)-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide |
| 02/05/2008 | US7326732 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders |
| 02/05/2008 | US7326731 Muscarinic agonists |
| 02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
| 02/05/2008 | CA2449445C Fluorous triphase and other multiphase systems |
| 02/05/2008 | CA2413515C Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them |
| 02/05/2008 | CA2284977C 3,3-disubstituted propylamines, their use and preparation |
| 01/31/2008 | WO2008013009A1 Polymer-supported metal complex catalyst |
| 01/31/2008 | US20080027236 Acid-catalyzed dehydration of fructose in 1-methyl-2-pyrrolidinone, dimethylacetamide, or dimethylformamide with a catalyst; end-capped polyethylene glycol eliminates the formation of undesirable PEG-HMF ethers |
| 01/31/2008 | US20080027235 Method for Producing Optically Active Cyclopropanecarboxylate Compound |
| 01/31/2008 | US20080027228 Substituted thioacetamides |
| 01/31/2008 | US20080027109 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 01/31/2008 | US20080027098 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPARalpha activation |
| 01/31/2008 | US20080027077 Novel biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/31/2008 | US20080027061 omega-Carboxy Aryl Substituted Diphenyl Ureas As p38 Kinase Inhibitors |
| 01/31/2008 | US20080027060 Dipeptide nitriles |
| 01/31/2008 | US20080027049 Benzofurans as potassium ion channel modulators |
| 01/31/2008 | US20080027036 S1P receptor modulating compounds and use thereof |
| 01/31/2008 | US20080025940 Administration of 3-sulfanylpropanamide compounds for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof |
| 01/30/2008 | EP1881961A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 01/30/2008 | EP1881958A1 Diacylglycerol acyltransferase inhibitors |
| 01/30/2008 | CN101115748A Acetamide compounds as fungicides |
| 01/30/2008 | CN101115719A Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| 01/30/2008 | CN101115711A Diacylglycerol acyltransferase inhibitors |
| 01/30/2008 | CN101113146A Process for the separation of blood fat recovery purpose-made monascus active ingredient |
| 01/30/2008 | CN101113145A Process for producing furfuraldehyde by corn and corn fabric by corn polyalcohol |
| 01/30/2008 | CN101113144A New compound and method for preparing same |
| 01/30/2008 | CN100364984C Production of metaphenyltrimethyl anhydride from metatrimethylbenzene by solid bed gas phase oxidation |
| 01/29/2008 | US7323608 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2008 | US7323577 Such as reacting Bromine and of 2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran in sodium acetate and acetonitrile to produce 5-Bromo-2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran |
| 01/29/2008 | US7323494 Liver X receptor(LXR) modulating agents, agonists; useful in increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, treating cardiovascular disease, inflammation; 2-[2-{[4-methoxy-benzyl](2,2-diphenylethyl)amino}ethyl]-5-benzofuran acetic acid |
| 01/29/2008 | CA2432664C Process for producing 3-methyltetrahydrofuran, and process for producing an intermediate thereof |
| 01/29/2008 | CA2220999C Process for the hydrogenation of imines |
| 01/29/2008 | CA2140928C Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/29/2008 | CA2136120C Treatment of incontinence |
| 01/24/2008 | WO2008010481A1 Aminoindan derivative or salt thereof |
| 01/24/2008 | WO2008009881A1 Chemical compounds |
| 01/24/2008 | WO2008009695A1 Rearrangement of spirolactams |
| 01/24/2008 | WO2008009459A1 Pharmacokinetic modelling of mycophenolic acid |
| 01/24/2008 | WO2007137247A3 Treatment for depressive disorders |
| 01/24/2008 | WO2007136948A3 Cyclic hydrofluoroether compounds and processes for their preparation and use |
| 01/24/2008 | WO2007091697A3 Method for preparing prostaglandin derivative |
| 01/24/2008 | US20080021222 Reacting an organic amine compound with a carbamyl-group-containing amide compound in the presence of a suitable polar or nonpolar aprotic, substantially anhydrous solvent or mixtures thereof; used as therapeutic agents for IMPDH-mediated diseases |
| 01/24/2008 | US20080021201 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/24/2008 | US20080021088 Retinoid Derivatives With Antiangiogenic, Antitumoral And Proapoptotic Activities |
| 01/24/2008 | US20080021087 Carbamoylamino-substituted 2,3-dihydro-benzofurans, indoles and benzothiophenes, e.g., (+)-N-((3R)-3-(4-isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide; cerebrovascular disorders |
| 01/24/2008 | US20080021025 Inhibitors of cathepsin s |
| 01/24/2008 | US20080020963 11-Methyl-13-Tridecanolide, 12-Methyl-14-Tetradecanolide And 13-Methyl-15-Pentadecanolide, Perfume Compositions Containing The Same, And Process For Production Of Compounds Including The Same |
| 01/24/2008 | CA2658376A1 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexane-1-derivatives having effects of the opioid receptor system |
| 01/23/2008 | EP1880720A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same |
| 01/23/2008 | EP1879876A2 Novel rhodamine dyes |
| 01/23/2008 | EP1879875A1 Crystal forms opf {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride |
| 01/23/2008 | EP1879858A2 Processes for preparing biaryl ureas and analogs thereof |
| 01/23/2008 | EP1879850A1 Acrylic ester compound and manufacturing intermediate thereof, method for manufacturing acrylic ester compound, and latent electrostatic image bearing member, image forming method, image forming apparatus and process cartridge |
| 01/23/2008 | EP1879848A2 Method for the production of olefins from carbonyl compounds |
| 01/23/2008 | EP1105730B1 Enzyme inhibition immunoassay |
| 01/23/2008 | CN101111493A 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
| 01/23/2008 | CN101108841A Compound and use thereof |
| 01/23/2008 | CN101108840A Chirality anona squamosa L. lactone compound with conformation limitation structure and synthesizing method and use thereof |
| 01/23/2008 | CN101108839A System and method of manufacturing furol with pentose solution |
| 01/23/2008 | CN101108838A System and method of manufacturing furol with pentose solution |
| 01/23/2008 | CN101108837A Method for preparing halogenated allyl-furfuryl alcohol |
| 01/23/2008 | CN101108358A Complex acid catalyst |
| 01/23/2008 | CN100363410C Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents |
| 01/23/2008 | CN100363369C Laminated organic-inorganic perofskite with metal defect inorganic frame |
| 01/23/2008 | CN100363355C Method for preparing alkyloxy furnanone derivatives, compounds obtained by said method and use of said compounds |
| 01/22/2008 | US7321063 Sulfonamide inhibitors of aspartyl protease |
| 01/22/2008 | US7321001 carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer |
| 01/22/2008 | US7320997 Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease |
| 01/22/2008 | US7320983 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 01/22/2008 | US7320803 Free from water of crystallization; use in foods, animal feeds, or in food supplements |
| 01/17/2008 | WO2008008954A2 Isothiocyanates and glucosinolate compounds and anti-tumor compositios containing same |
| 01/17/2008 | WO2008008660A2 Cyclopentane derivatives as antiglaucoma agents |
| 01/17/2008 | WO2008007132A1 Tetrahydrofuro [3, 2-b] pyrr0l-3-0ne intermediates |
| 01/17/2008 | WO2008006626A1 Triphenyl modified 5-membered heterocycles and their use as anticancer and antiinflammatory agents |
| 01/17/2008 | WO2008006276A1 THE SMALL MOLECULE INHIBITOR WHICH CAN INHIBIT THE AβPOLYPEPTIDE FIBROSIS OF ALZHEIMER'S DISEASE, THEIR PREPAREATION METHODS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF |
| 01/17/2008 | WO2007135294A3 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |
| 01/17/2008 | WO2007135102A3 PRODUCTION OF PHTHALIC ANHYDRIDE BY GAS PHASE OXIDATION OF o-XYLOL IN A PRIMARY AND A SECONDARY REACTOR |
| 01/17/2008 | WO2007096647A3 Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer |
| 01/17/2008 | WO2007019080A3 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/17/2008 | US20080015364 Catalyst and Method for Preparing Phthalic Anhydride |
| 01/17/2008 | US20080015242 Use of N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydroxyethyl]phenyl]methanesulfonamide or salt for treating diabetes, obesity, hyperlipidemia and urinary incontinence; drug interaction side effect reduction |
| 01/17/2008 | US20080015219 Treating eye diseases including glaucoma or ocular hypertension; selective prostaglandin EP2 agonists; acid-functional aryl substituted cyclopentanone or hydroxycyclopentane compounds |
| 01/17/2008 | US20080015195 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase |